In a report released on February 2, Tobey Sommer from Truist Financial reiterated a Buy rating on Exponent (EXPO – Research Report), with a price target of $120.00. The company’s shares opened today at $110.56.
According to TipRanks, Sommer is a 5-star analyst with an average return of 14.8% and a 64.06% success rate. Sommer covers the Services sector, focusing on stocks such as Korn Ferry, ManpowerGroup, and IBEX.
Currently, the analyst consensus on Exponent is a Moderate Buy with an average price target of $120.00.
See today’s best-performing stocks on TipRanks >>
EXPO market cap is currently $5.63B and has a P/E ratio of 56.77.
Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EXPO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of solutions. It operates through two segments: Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment provides technical consulting in different practices primarily in engineering. The Environmental and Health segment gives services in the area of environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1989 and is headquartered in Menlo Park, CA.
Read More on EXPO:
- Exponent increases quarterly dividend payment from 24c to 26c per share
- Exponent reports Q4 EPS 44c, two estimates 39c
- Exponent sees FY23 EBITDA 28%-28.5% of revenues before reimbursements
- Exponent Reports Fourth Quarter and Fiscal Year 2022 Financial Results
- Exponent sees Q1 EBITDA 27.5%-28.2% of revenues before reimbursements
